Proteome Sciences Share Discussion Threads

[monte1] 01/4/2021 10:17

Once more pools2 - this time in English please.

tia

Edit - translated version now noted.

[pools2] 01/4/2021 10:16

Coming from our self professed expert who was telling us a short while ago that PRM needed £6.5 million revenue just to break even.

[jeffian] 01/4/2021 10:11

Well it's hard to fathom what is going on but at the heart of it we have a company which is less profitable at the operating level but has generated cash and a better bottom line by slashing administrative costs in an inexplicable way.

The huge improvement in the second half comes entirely from the massive drop in Administrative Expenses (a mere £654k apparently against previous half-years when it has been running at c.£1.2-£1.3m). I'm also interested to note that they show total Administrative expenses for the year down to £2.036m and yet staff costs alone are £2.15m. How does that work?

There is a blurring of Operating and Administrative costs into 'total costs' but the plain fact is that the Gross Profit margin has remained pretty constant for years around 55% producing a GP this year of £550k to run the business. Hmmmm.

[wrighty41] 01/4/2021 10:06

This co is now profitable with a decent outlook over next 3-5yrs.
A good place to be IMO.
W41

[small crow] 01/4/2021 09:41

Ah well, we didn't get to where we are today by over-delivering ...

[madmick] 01/4/2021 09:40

Lol If we hadn't hired the above CEO. we would have had £500,000 profit.

[monte1] 01/4/2021 09:17

Good morning Randhoax_Girl

[elpirata] 01/4/2021 09:14

Investor Presentation

Proteome Sciences PLC is pleased to announce that Chief Executive Officer, Dr Mariola Soehngen, will provide a live presentation relating to the Company's results for the year ended 31 December 2020 via the Investor Meet Company platform on Thursday, 8 April 2021 at 10.00am BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and select to meet Proteome Sciences PLC via:

Investors who already follow Proteome Sciences PLC on the Investor Meet Company platform will automatically be invited.

[the bull] 01/4/2021 08:37

Slightly underwhelmed by the results

[wasjobber] 01/4/2021 08:36

Why doesn't PRM tell us about their recent Ck1d therapeutic patent grant on 27th October last year in their final results for 2020 today ???





Answers on a postcard please

[elpirata] 01/4/2021 08:31

goatherd 29 Mar '21 - 18:35 - 58753 of 58789
0 4 0
I have a suspicion (entirely without evidence) that the demand could be coming from the Randox side as I am expecting their CE anytime

BOL!

[elpirata] 01/4/2021 08:30

quite right monte1, I note the re-rating is in play

[monte1] 01/4/2021 08:05

They are not having mine cheap.

[mashman] 01/4/2021 08:02

Now they are going to bore you out of your shares

[peverill] 01/4/2021 08:00

As you were!!!!.

[tom barnaby] 01/4/2021 07:39

I note that the increase in cash was primarily due to a significant Prepayment and 'managing' creditors.

[csmwssk12hu] 01/4/2021 07:37

A little bit more than expected ten times more!

[monte1] 01/4/2021 07:35

How veerrry dare you.

[monte1] 01/4/2021 07:22

Stunning results.

I wouldn’t want to be out of this over the weekend.

Bravo PRM.

[bluemango] 01/4/2021 07:21

Just phoned the dealers and asked to put my Lamborghini order on hold for now.

[stocktastic] 01/4/2021 07:21

Agreed Wrighty

[stocktastic] 01/4/2021 07:20

Results as expected
A little bit more profit,but still insignificant

Yet again, the rampers and fanboy commentators like pools2, Zak, proven to be over-excited or wrong. Pools2 (jt?),do you never learn?

Pathetic progress with stroke. Trials in general did pause though
It shows the degree to which Randox's comms dept was lying or misleading back in 2018? Earlier? When they said CE mark by year end. They would have known at that point, they couldnt possibly have been anywhere near!!
Randox girl yet again proven wrong


So, progress,but no more than anticipated and still slow

Thw CEO still reviewing 6 months later. If looking for bolt on deals, that csn take time, but it feels like she is slow to actually add any value
Pike could have managed the same consulting firm they are presumably using for the external opportunity review. I remsin of the view that the CEO role is a waste of cash here